Acadia Healthcare CEO Christopher Hunter departs; separation agreement filed
Acadia Healthcare's Chief Executive Officer Christopher Hunter left the role and the Board of Directors effective January 20, 2026. His separation agreement provides cash severance, a $1,785,000 retention bonus payment, and continued eligibility for 2025 bonus and prorated performance stock units, while unvested equity was forfeited.
Key points
- Departure effective January 20, 2026; Hunter also resigned from the Board
- Severance equal to 1.5 times base salary plus 2025 target bonus, paid over 18 months
- Lump sum retention bonus payment of $1,785,000
- Unvested equity forfeited; prorated PSUs remain outstanding subject to performance conditions
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:38 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 23, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.